Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin in T2D with Severe Renal Impairment (CKD4)
NCT03242018Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Aug 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of sotagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Lexicon Pharmaceuticals, Inc.. Started Aug 2017; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03242018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03242018.